CEO Brian Adams was paid $2,301,712 in fiscal year 2022, ↓ down 7.1% from fiscal year 2021, the 7th percentile of its disclosed peer group (SEC filing 0001104659-23-052070 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$5,984,015 Calvin Knowlton total, FY2022 Former Chief Executive Officer — highest-paid officer; CEO Brian Adams: $2,301,712 | 7th CEO (Brian Adams) pay percentile vs peers | 31.1:1 CEO-to-median pay ratio | 96.31% Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
Ask our research desk — $99, 24h, every figure cited to its filing.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Calvin Knowlton | $482,119 | $0 | $2,654,433 | $0 | $0 | $0 | $2,847,463 | $5,984,015 |
| Former Chief Executive Officer | ||||||||
| Brian Adams | 450,000 | 0 | 1,633,498 | 0 | 190,688 | 0 | 27,526 | 2,301,712 |
| President and Chief Executive Officer | ||||||||
| Michael Greenhalgh | 407,846 | 50,000 | 1,225,123 | 0 | 139,668 | 0 | 33,390 | 1,856,027 |
| Chief Operating Officer | ||||||||
| Thomas Cancro | 311,190 | 0 | 934,000 | 0 | 90,047 | 0 | 59,944 | 1,395,181 |
| Chief Financial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2022 total | FY2021 total | FY2020 total | Δ FY2021→2022 |
|---|---|---|---|---|
| Calvin Knowlton | $5,984,015 | $5,971,425 | $4,602,660 | ↑ +12,590 |
| Brian Adams | 2,301,712 | 2,476,505 | 1,925,199 | ↓ −174,793 |
| Michael Greenhalgh | 1,856,027 | 2,468,668 | 1,424,907 | ↓ −612,641 |
| Thomas Cancro | 1,395,181 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read Tabula Rasa HealthCare's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper TRHC reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
How we handle your data → Privacy
Each company listed discloses TRHC in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named TRHC in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
No insider equity transactions reported since the proxy statement.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Thomas Cancro | RSU | 2022-02-24 | — | — | 200,000 | — | $934,000 |
| Michael Greenhalgh | RSU | 2022-08-01 | — | — | 150,000 | — | 568,500 |
| Calvin Knowlton | RSU | 2022-08-01 | — | — | 200,000 | — | 758,000 |
| Brian Adams | RSU | 2022-08-01 | — | — | 200,000 | — | 758,000 |
| Calvin Knowlton | RSU | 2022-08-01 | — | — | 325,000 | — | 1,231,750 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Thomas Cancro | $934,000 | $0 | $0 | 0.0% |
| Michael Greenhalgh | 568,500 | 0 | 0 | 0.0% |
| Calvin Knowlton | 1,989,750 | 0 | 0 | 0.0% |
| Brian Adams | 758,000 | 0 | 0 | 0.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Brian Adams | PSU | 7,031 | — | $34,803 |
| Michael Greenhalgh | PSU | 37,500 | — | 185,625 |
| Thomas Cancro | RSU | 200,000 | — | 990,000 |
| Brian Adams | RSU | 200,000 | — | 990,000 |
| Michael Greenhalgh | RSU | 150,000 | — | 742,500 |
| Brian Adams | PSU | 50,000 | — | 247,500 |
| Brian Adams | RSU | 21,094 | — | 104,415 |
| Michael Greenhalgh | RSU | 21,094 | — | 104,415 |
| Brian Adams | RSU | 11,013 | — | 54,514 |
| Brian Adams | RSU | 9,000 | — | 44,550 |
| Michael Greenhalgh | RSU | 7,342 | — | 36,343 |
| Michael Greenhalgh | PSU | 7,031 | — | 34,803 |
| Michael Greenhalgh | RSU | 3,500 | — | 17,325 |
| Brian Adams | Option | 42,153 | 3.11 | — |
| Brian Adams | Option | 39,347 | 13.78 | — |
| Brian Adams | Option | 21,350 | 14.23 | — |
| Michael Greenhalgh | Option | 25,000 | 3.11 | — |
| Michael Greenhalgh | Option | 14,500 | 14.23 | — |
| Michael Greenhalgh | Option | 21,847 | 13.78 | — |
The Company's compensation program is designed to attract and retain individuals of superior ability, align executive pay with corporate and individual performance, and maximize stockholder value creation by providing a portion of total compensation in equity. The program uses a mix of short- and long-term performance metrics to link compensation achievement to business objectives.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Pearl Meyer & Partners, LLC |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2023 | 2023-06-09 | 15,984,400 | 595,775 | 17,248 | 96.31% | Passed |
| 2022 | 2022-06-10 | 3,804,433 | 11,512,639 | 154,052 | 24.59% | Failed |
| 2021 | 2021-06-11 | 16,235,855 | 1,985,837 | 36,905 | 88.92% | Passed |
| 2020 | 2020-06-12 | 13,668,728 | 1,720,382 | 59,716 | 88.48% | Passed |
| 2019 | 2019-06-14 | 11,283,693 | 1,328,948 | 37,857 | 89.2% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2023 | 2023-06-09 | 96.31%a |
| 2022 | 2022-06-10 | 24.59%b |
| 2021 | 2021-06-11 | 88.92%c |
a. Approved under the standard stated in the filing — “Abstentions will have the same effect as an " AGAINST " vote, and broker non-votes will have no effect.”.
b. Approved under the standard stated in the filing — “Abstentions will have the same effect as an "Against" vote, and broker non-votes will have no effect.”.
c. Approved under the standard stated in the filing — “Abstentions will have the same effect as an "Against" vote, and broker non-votes will have no effect.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 31.1 : 1 |
|---|---|
| CEO total compensation | — |
| Median employee compensation | $74,075 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Jan BergerIndependent · Not standing for re-election | $65,250 | $166,957 | — | — | $50,000 | $282,207 |
| Michael PurcellIndependent · Board Chair · Audit (Chair) · Compensation · Strategic Review · Nominating & Governance · Scientific Application | 70,750 | 187,031 | — | — | 0 | 257,781 |
| Jonathan D. SchwartzIndependent · Nominating and Governance (Chair) · Audit · Compensation · Newly elected | 17,500 | 239,999 | — | — | 0 | 257,499 |
| Ronald MitchellIndependent · Compensation · Strategic Review · Newly elected | 15,625 | 239,999 | — | — | 0 | 255,624 |
| Derek C. SchrierIndependent · Strategic Review (Chair) · Newly elected | 15,000 | 239,999 | — | — | 0 | 254,999 |
| A Gordon TunstallNot independent · Departed during FY | 26,875 | 219,096 | — | — | 0 | 245,971 |
| Samira BeckwithIndependent · Scientific Application (Chair) · Audit | 54,750 | 184,720 | — | — | 0 | 239,470 |
| Dennis K. HellingIndependent · Nominating and Governance · Scientific Application | 34,125 | 201,406 | — | — | 0 | 235,531 |
| Kathrine O'Brien | 64,375 | 166,957 | — | — | 0 | 231,332 |
| Pamela SchweitzerIndependent · Compensation · Scientific Application | 55,250 | 174,421 | — | — | 0 | 229,671 |
| Brian W. AdamsEmployee director · Newly elected | — | — | — | — | — | 0 |
| Annual cash retainer | $50,000 |
|---|---|
| Annual equity retainer | $160,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 20,000 / 15,000 / 10,000 |
| Stock ownership guideline | $5 |
| Component | FY2022 |
|---|---|
| Cash retainers and fees | $419,500 |
| Equity awards (grant-date value) | $2,020,585 |
| All other compensation | $50,000 |
| Total cost of the board | $2,490,085 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies Tabula Rasa HealthCare names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Tabula Rasa HealthCare.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Hims & Hers Health, Inc. | 2025 | Andrew Dudum | $494,792 | $10,635,352 | $11,000,000 | $585,763 | $22,958,907 |
| 2 | Vocera Communications, Inc. | 2025 | Bruce McClelland | 750,000 | 16,370,820 | 0 | 225,188 | 17,457,675 |
| 3 | Evolent Health, Inc. | 2025 | Seth Blackley | 867,068 | 12,699,086 | 0 | 0 | 14,240,154 |
| 4 | HealthEquity, Inc. | 2026 | Scott Cutler | 775,000 | 12,038,563 | 0 | 767,250 | 13,582,105 |
| 5 | 1Life Healthcare, Inc. | 2025 | Peter Scott | 534,091 | 10,336,831 | 0 | 1,984,500 | 12,855,422 |
| 6 | National Research Corporation | 2025 | Trent Green | 697,115 | 6,755,000 | 0 | 0 | 11,961,900 |
| 7 | Benefitfocus, Inc. | 2021 | Matthew Levin | 349,038 | 7,464,355 | 0 | 278,780 | 8,098,139 |
| 8 | Phreesia, Inc. | 2026 | Chaim Indig | 515,000 | 7,562,706 | 0 | 0 | 8,077,706 |
| 9 | Omnicell, Inc. | 2025 | Randall Lipps | 846,891 | 5,219,576 | 0 | 1,411,485 | 7,531,852 |
| 10 | American Well Corporation | 2025 | Ido Schoenberg | 701,755 | 1,294,331 | 0 | 2,010,100 | 4,162,171 |
| 11 | Health Catalyst, Inc. | 2025 | Daniel Burton | 525,000 | 3,444,040 | 0 | 0 | 3,991,159 |
| 12 | Accolade, Inc. | 2024 | Rajeev Singh | 500,000 | 3,320,097 | 0 | 0 | 3,823,597 |
| 13 | eHealth, Inc. | 2025 | Derrick Duke | 290,769 | 1,956,000 | 0 | 414,247 | 3,262,665 |
| 14 | Tabula Rasa HealthCare | 2022 | Brian Adams | 450,000 | 1,633,498 | 0 | 190,688 | 2,301,712 |
| 15 | HealthStream, Inc. | 2025 | Robert Frist | 400,500 | 224,977 | 79,550 | 158,100 | 868,037 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Tabula Rasa HealthCare | not disclosed | PSU 50 · RSU 50 | not disclosed | Pearl Meyer & Partners, LLC |
| 1Life Healthcare, Inc. | 147% | PSU 60 · RSU 40 | Yes — Relative TSR compared to the TSR peer group | Ferguson Partners |
| Accolade, Inc. | not disclosed | PSU 50 · RSU 50 | No | FW Cook |
| American Well Corporation | not disclosed | PSU 45 · Cash LTI 45 · RSU 10 | No | Aon |
| Benefitfocus, Inc. | 100.7% | PSU 50 · RSU 50 | No | Compensia |
| eHealth, Inc. | not disclosed | PSU 50 · RSU 50 | No | Aon |
| Evolent Health, Inc. | 75% | PSU 70 · RSU 30 | No | Exequity |
| Health Catalyst, Inc. | 39% | RSU 50 · PSU 50 | Yes — TSR Achievement | Aon (Human Capital Solutions practice) |
| HealthEquity, Inc. | 99% | PSU 60 · RSU 40 | Yes | Semler Brossy |
| HealthStream, Inc. | 97.6% | not disclosed | No | not disclosed |
| Hims & Hers Health, Inc. | 93.72% | Options 51 · RSU 49 | No | Compensia, Inc. |
| National Research Corporation | not disclosed | not disclosed | not disclosed | not disclosed |
| Omnicell, Inc. | 133.3% | RSU 50 · PSU 50 | No | Exequity |
| Phreesia, Inc. | 140.3% | PSU 50 · RSU 50 | Yes — Relative TSR | FW Cook, Inc. |
| Vocera Communications, Inc. | 30% | not disclosed | Yes — Relative TSR | FW Cook |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Calvin Knowlton | DEF 14A | 2023-04-28 | 0001104659-23-052070 | Section “Compensation Tables”. As printed: 5,984,015. Filing ↗machine: r8 · c42 · span 1318321–1318330 |
| 2 | Section 01, Brian Adams | DEF 14A | 2023-04-28 | 0001104659-23-052070 | Section “Compensation Tables”. As printed: 2,301,712. Filing ↗machine: r1 · c42 · span 1278656–1278665 |
| 3 | Section 01, Michael Greenhalgh | DEF 14A | 2023-04-28 | 0001104659-23-052070 | Section “Compensation Tables”. As printed: 1,856,027. Filing ↗machine: r5 · c42 · span 1301433–1301442 |
| 4 | Section 01, Thomas Cancro | DEF 14A | 2023-04-28 | 0001104659-23-052070 | Section “Compensation Tables”. As printed: 1,395,181. Filing ↗machine: r4 · c42 · span 1295217–1295226 |
| 5 | Section 03, Thomas Cancro RSU | DEF 14A | 2023-04-28 | 0001104659-23-052070 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1204670–1204677 |
| 6 | Section 03, Michael Greenhalgh RSU | DEF 14A | 2023-04-28 | 0001104659-23-052070 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1208842–1208849 |
| 7 | Section 03, Calvin Knowlton RSU | DEF 14A | 2023-04-28 | 0001104659-23-052070 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1217206–1217213 |
| 8 | Section 03, Brian Adams RSU | DEF 14A | 2023-04-28 | 0001104659-23-052070 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1200507–1200514 |
| 9 | Section 03, Calvin Knowlton RSU | DEF 14A | 2023-04-28 | 0001104659-23-052070 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1213022–1213031 |
| 10 | Section 07, pay ratio | DEF 14A | 2023-04-28 | 0001104659-23-052070 | Section “CEO Pay Ratio”. As printed: 31.1 : 1. Filing ↗ |
| 11 | Section 08, Jan Berger | DEF 14A | 2023-04-28 | 0001104659-23-052070 | Section “Director Compensation”. As printed: 282,207. Filing ↗machine: span 905520–905527 |
| 12 | Section 08, Michael Purcell | DEF 14A | 2023-04-28 | 0001104659-23-052070 | Section “Director Compensation”. As printed: 257,781. Filing ↗machine: span 919637–919644 |
| 13 | Section 08, Jonathan D. Schwartz | DEF 14A | 2023-04-28 | 0001104659-23-052070 | Section “Director Compensation”. As printed: 257,499. Filing ↗machine: span 926694–926701 |
| 14 | Section 08, Ronald Mitchell | DEF 14A | 2023-04-28 | 0001104659-23-052070 | Section “Director Compensation”. As printed: 255,624. Filing ↗machine: span 912576–912583 |
| 15 | Section 08, Derek C. Schrier | DEF 14A | 2023-04-28 | 0001104659-23-052070 | Section “Director Compensation”. As printed: 254,999. Filing ↗machine: span 923165–923172 |
| 16 | Section 08, A Gordon Tunstall | DEF 14A | 2023-04-28 | 0001104659-23-052070 | Section “Director Compensation”. As printed: 245,971. Filing ↗machine: span 933678–933685 |
| 17 | Section 08, Samira Beckwith | DEF 14A | 2023-04-28 | 0001104659-23-052070 | Section “Director Compensation”. As printed: 239,470. Filing ↗machine: span 901999–902006 |
| 18 | Section 08, Dennis K. Helling | DEF 14A | 2023-04-28 | 0001104659-23-052070 | Section “Director Compensation”. As printed: 235,531. Filing ↗machine: span 909049–909056 |
| 19 | Section 08, Kathrine O'Brien | DEF 14A | 2023-04-28 | 0001104659-23-052070 | Section “Director Compensation”. As printed: 231,332. Filing ↗machine: span 916110–916117 |
| 20 | Section 08, Pamela Schweitzer | DEF 14A | 2023-04-28 | 0001104659-23-052070 | Section “Director Compensation”. As printed: 229,671. Filing ↗machine: span 930224–930231 |
| 21 | Section 08, Brian W. Adams | DEF 14A | 2023-04-28 | 0001104659-23-052070 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 22 | Section 06, 2023 vote | Form 8-K | 2023-06-14 | 0001104659-23-071021 | Item 5.07 · say-on-pay result. As reported: 96.31% (votes for as printed: 15,984,400). Filing ↗ |
| 23 | Section 06, 2022 vote | Form 8-K | 2022-06-16 | 0001104659-22-071875 | Item 5.07 · say-on-pay result. As reported: 24.59% (votes for as printed: 3,804,433). Filing ↗ |
| 24 | Section 06, 2021 vote | Form 8-K | 2021-06-17 | 0001104659-21-082593 | Item 5.07 · say-on-pay result. As reported: 88.92% (votes for as printed: 16,235,855). Filing ↗ |
| 25 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 26 | Section 03b vehicle mix (computed) | Computed | — | — | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 27 | Section 09b board cost (computed) | Computed | — | — | Cash 419,500 + equity 2,020,585 + all other 50,000 = 2,490,085, summed across the director compensation table rows.machine: formula: Σ = 2,490,085 |
| 28 | Hims & Hers Health, Inc., Section 10b CEO total | DEF 14A | 2026-04-28 | 0001773751-26-000060 | CEO total compensation as printed in Hims & Hers Health, Inc.'s own proxy. As printed: 22,958,907. Filing ↗machine: r3 · c27 · span 587953–587963 |
| 29 | Vocera Communications, Inc., Section 10b CEO total | DEF 14A | 2026-04-17 | 0001104659-26-044643 | CEO total compensation as printed in Vocera Communications, Inc.'s own proxy. As printed: 17,457,675. Filing ↗machine: t160 · r1 · c42 · span 1626864–1626874 |
| 30 | Evolent Health, Inc., Section 10b CEO total | DEF 14A | 2026-04-24 | 0001193125-26-177267 | CEO total compensation as printed in Evolent Health, Inc.'s own proxy. As printed: 14,240,154. Filing ↗machine: r3 · c20 · span 908544–908555 |
| 31 | HealthEquity, Inc., Section 10b CEO total | DEF 14A | 2026-05-13 | 0001428336-26-000022 | CEO total compensation as printed in HealthEquity, Inc.'s own proxy. As printed: 13,582,105. Filing ↗machine: r3 · c21 · span 892475–892485 |
| 32 | 1Life Healthcare, Inc., Section 10b CEO total | DEF 14A | 2026-04-07 | 0001360604-26-000032 | CEO total compensation as printed in 1Life Healthcare, Inc.'s own proxy. As printed: 12,855,422. Filing ↗machine: r2 · c21 · span 598192–598203 |
| 33 | National Research Corporation, Section 10b CEO total | DEF 14A | 2026-05-08 | 0001437749-26-015775 | CEO total compensation as printed in National Research Corporation's own proxy. As printed: 11,961,900. Filing ↗machine: t69 · r2 · c29 · span 454149–454159 |
| 34 | Benefitfocus, Inc., Section 10b CEO total | DEF 14A | 2022-05-09 | 0001104659-22-057495 | CEO total compensation as printed in Benefitfocus, Inc.'s own proxy. As printed: 8,098,139. Filing ↗machine: t45 · r1 · c35 · span 1150629–1150638 |
| 35 | Phreesia, Inc., Section 10b CEO total | DEF 14A | 2026-05-14 | 0001412408-26-000155 | CEO total compensation as printed in Phreesia, Inc.'s own proxy. As printed: 8,077,706. Filing ↗machine: span 634967–634976 |
| 36 | Omnicell, Inc., Section 10b CEO total | DEF 14A | 2026-04-13 | 0001104659-26-042631 | CEO total compensation as printed in Omnicell, Inc.'s own proxy. As printed: 7,531,852. Filing ↗machine: r1 · c47 · span 668949–668958 |
| 37 | American Well Corporation, Section 10b CEO total | DEF 14A | 2026-04-23 | 0001393584-26-000008 | CEO total compensation as printed in American Well Corporation's own proxy. As printed: 4,162,171. Filing ↗machine: r2 · c14 · span 771018–771028 |
| 38 | Health Catalyst, Inc., Section 10b CEO total | DEF 14A | 2026-06-03 | 0001636422-26-000075 | CEO total compensation as printed in Health Catalyst, Inc.'s own proxy. As printed: 3,991,159. Filing ↗machine: span 702084–702093 |
| 39 | Accolade, Inc., Section 10b CEO total | DEF 14A | 2024-06-21 | 0001481646-24-000029 | CEO total compensation as printed in Accolade, Inc.'s own proxy. As printed: 3,823,597. Filing ↗machine: r2 · c42 · span 399607–399616 |
| 40 | eHealth, Inc., Section 10b CEO total | DEF 14A | 2026-04-28 | 0001333493-26-000020 | CEO total compensation as printed in eHealth, Inc.'s own proxy. As printed: 3,262,665. Filing ↗machine: t62 · r3 · c16 · span 885391–885400 |
| 41 | Tabula Rasa HealthCare (subject), Section 10b CEO total | DEF 14A | 2023-04-28 | 0001104659-23-052070 | CEO total compensation as printed in Tabula Rasa HealthCare's own proxy. As printed: 2,301,712. Filing ↗machine: r1 · c42 · span 1278656–1278665 |
| 42 | HealthStream, Inc., Section 10b CEO total | DEF 14A | 2026-04-10 | 0001437749-26-012017 | CEO total compensation as printed in HealthStream, Inc.'s own proxy. As printed: 868,037. Filing ↗machine: span 501227–501234 |
| 43 | Section 10a, Accolade, Inc. reciprocity | DEF 14A | — | 0001481646-24-000029 | Accolade, Inc. names Tabula Rasa HealthCare in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 44 | Section 10a, 1Life Healthcare, Inc. reciprocity | DEF 14A | — | 0001360604-26-000032 | 1Life Healthcare, Inc.'s most recent proxy was read; its disclosed peer group does not include Tabula Rasa HealthCare. Filing ↗ |
| 45 | Section 10a, Vocera Communications, Inc. reciprocity | DEF 14A | — | 0001104659-26-044643 | Vocera Communications, Inc.'s most recent proxy was read; its disclosed peer group does not include Tabula Rasa HealthCare. Filing ↗ |
| 46 | Section 10a, HealthEquity, Inc. reciprocity | DEF 14A | — | 0001428336-26-000022 | HealthEquity, Inc.'s most recent proxy was read; its disclosed peer group does not include Tabula Rasa HealthCare. Filing ↗ |
| 47 | Section 10a, Evolent Health, Inc. reciprocity | DEF 14A | — | 0001193125-26-177267 | Evolent Health, Inc.'s most recent proxy was read; its disclosed peer group does not include Tabula Rasa HealthCare. Filing ↗ |
| 48 | Section 10a, eHealth, Inc. reciprocity | DEF 14A | — | 0001333493-25-000047 | eHealth, Inc. names Tabula Rasa HealthCare in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 49 | Section 10a, Phreesia, Inc. reciprocity | DEF 14A | — | 0001412408-26-000155 | Phreesia, Inc.'s most recent proxy was read; its disclosed peer group does not include Tabula Rasa HealthCare. Filing ↗ |
| 50 | Section 10a, American Well Corporation reciprocity | DEF 14A | — | 0001393584-26-000008 | American Well Corporation's most recent proxy was read; its disclosed peer group does not include Tabula Rasa HealthCare. Filing ↗ |
| 51 | Section 10a, Health Catalyst, Inc. reciprocity | DEF 14A | — | 0001636422-26-000075 | Health Catalyst, Inc.'s most recent proxy was read; its disclosed peer group does not include Tabula Rasa HealthCare. Filing ↗ |
| 52 | Section 10a, Benefitfocus, Inc. reciprocity | DEF 14A | — | 0001104659-22-057495 | Benefitfocus, Inc. names Tabula Rasa HealthCare in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 53 | Section 10a, Omnicell, Inc. reciprocity | DEF 14A | — | 0001104659-26-042631 | Omnicell, Inc.'s most recent proxy was read; its disclosed peer group does not include Tabula Rasa HealthCare. Filing ↗ |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.